EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EU

Sophie Brunner Ziegler iD, Fabian Eibensteiner iD, Nina Reumann, Martin Brunner, Franz König iD, Eva Maria Zebedin Brandl iD

Clinical and Translational Science · 2026-05 · 19 (5)

DOI: 10.1111/cts.70580 ↗

At a glance

Journal article in Clinical and Translational Science, published online on 2026-05-03. Written by Sophie Brunner Ziegler and 5 co-authors. Institution: Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria. Major MEDLINE topics: Consent Forms, Comprehension, Informed Consent, Clinical Trials, Phase III as Topic. 44 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The Clinical Trials Information System (CTIS) enables a central joint registration of clinical trials in the EU and provides public access to key trial documents including informed consent documents. The increasing complexity and length of subject information sheets and informed consent forms (SIS/ICFs) can impact participant comprehension and willingness to enroll in a trial. This pilot study aimed to analyze the characteristics of actual SIS/ICFs from a sample of approved CTIS submissions, with a focus on Phase III trials. We consulted the CTIS public database to retrieve authorized Phase III trials. The final dataset comprised 67 drug trials submitted between January 1, 2023, and November 16, 2023. SIS/ICF page and word count, and readability scores were compared across countries, sponsorship, and other trial‐related characteristics. Exploratory analyses assessed document structure and page space utilization. The median SIS/ICF length was 16 pages (IQR 11–23) and 5746 words (IQR 3508–8626), with substantial variability. Industry‐sponsored trials had significantly longer SIS/ICFs than academic trials (mean difference + 8.1 pages, p < 0.01). German SIS/ICFs were on average 4.4 pages longer than Austrian SIS/ICFs ( p = 0.018). Exploratory analyses suggested that formatting choices, repetition, and expanded data protection sections contributed more to length differences than content allocation or readability, thus indicating that the main drivers of SIS/ICF length are modifiable in nature. These findings underscore the need for further research into the factors influencing document length, their implications for trial participants and how a further harmonization throughout the EU can be achieved for country‐specific documents.

Subjects

MeSH terms (MEDLINE)

Consent FormsComprehensionInformed ConsentClinical Trials, Phase III as TopicClinical Trials as TopicPilot ProjectsHumansEuropean Union

Authors and institutions

  • Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
  • Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Division of Paediatric Nephrology and Gastroenterology, Department of Paediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Ethics Committee (Institutional Review Board) of the Medical University of Vienna, Vienna, Austria.

ORCID profiles: Sophie Brunner Ziegler, Fabian Eibensteiner, Franz König, Eva Maria Zebedin Brandl

Cite

APA

Brunner Ziegler, S., Eibensteiner, F., Reumann, N., Brunner, M., König, F., & Zebedin Brandl, E. M. (2026). A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EU. Clinical and Translational Science, 19(5). https://doi.org/10.1111/cts.70580

Vancouver

Brunner Ziegler S, Eibensteiner F, Reumann N, Brunner M, König F, Zebedin Brandl EM. A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EU. Clinical and Translational Science. 2026;19(5). doi:10.1111/cts.70580

BibTeX
@article{BrunnerZiegler2026,
  author = {Brunner Ziegler, Sophie and Eibensteiner, Fabian and Reumann, Nina and Brunner, Martin and König, Franz and Zebedin Brandl, Eva Maria},
  title = {A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EU},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {5},
  doi = {10.1111/cts.70580}
}
Start for free →